Signal transduction by HDL: Agonists, receptors, and signaling cascades

Handbook of Experimental Pharmacology

Volumn 224, Issue , 2015, Pages 229-256

  Nofer, Jerzy Roch ^a  

^a UNIVERSITY HOSPITAL MÜNSTER   (Germany)

Author keywords

Apolipoprotein A I (apoA I); ATP binding cassette transporter A1 (ABCA1); High density lipoprotein (HDL); Scavenger receptor type I (SR BI); Signal transduction; Sphingosine 1 phosphate (S1P)

Indexed keywords

ABC TRANSPORTER A1; ABC TRANSPORTER G1; ADENOSINE TRIPHOSPHATASE; ADENYLATE CYCLASE; APOLIPOPROTEIN A1; CYCLIC AMP; CYCLOOXYGENASE 2; DIACYLGLYCEROL; HIGH DENSITY LIPOPROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; JANUS KINASE 2; PHOSPHATIDYLCHOLINE; PHOSPHATIDYLINOSITOL; PHOSPHOLIPASE C; PROTEIN CDC42; PROTEIN KINASE C; PURINERGIC P2Y12 RECEPTOR; PURINERGIC P2Y13 RECEPTOR; SCAVENGER RECEPTOR BI; SPHINGOSINE 1 PHOSPHATE; SPHINGOSYLPHOSPHORYLCHOLINE; STAT3 PROTEIN; SULFOGALACTOSYLSPHINGOSINE; TRANSFORMING GROWTH FACTOR BETA; VASCULAR CELL ADHESION MOLECULE 1; ABC TRANSPORTER; ABCA1 PROTEIN, HUMAN; ABCG1 PROTEIN, HUMAN; APOA1 PROTEIN, HUMAN; HIGH DENSITY LIPOPROTEIN RECEPTORS; LIGAND; LIPOPROTEIN RECEPTOR; LYSOPHOSPHOLIPID; P2RY12 PROTEIN, HUMAN; P2RY13 PROTEIN, HUMAN; PURINERGIC P2 RECEPTOR; SCARB1 PROTEIN, HUMAN; SCAVENGER RECEPTOR B; SPHINGOSINE; SPHINGOSINE 1-PHOSPHATE;

ANTIINFLAMMATORY ACTIVITY; BINDING SITE; CELL EXPANSION; CELL PROLIFERATION; CELL SURVIVAL; CHOLESTEROL METABOLISM; CONFERENCE PAPER; CYCLIC AMP RESPONSIVE ELEMENT; CYTOKINE PRODUCTION; HEART PROTECTION; HUMAN; INTERNALIZATION; LIPID TRANSPORT; MOLECULAR DOCKING; PROMOTER REGION; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTEIN STABILITY; PROTEIN TRANSPORT; SIGNAL TRANSDUCTION; TANGIER DISEASE; AGONISTS; ANALOGS AND DERIVATIVES; ANIMAL; ARTERY; ATHEROSCLEROSIS; BLOOD; METABOLISM; PATHOLOGY;

ADENOSINE TRIPHOSPHATASES; ANIMALS; APOLIPOPROTEIN A-I; ARTERIES; ATHEROSCLEROSIS; ATP BINDING CASSETTE TRANSPORTER 1; ATP-BINDING CASSETTE TRANSPORTERS; HUMANS; LIGANDS; LIPOPROTEINS, HDL; LYSOPHOSPHOLIPIDS; RECEPTORS, LIPOPROTEIN; RECEPTORS, PURINERGIC P2; RECEPTORS, PURINERGIC P2Y12; SCAVENGER RECEPTORS, CLASS B; SIGNAL TRANSDUCTION; SPHINGOSINE;

EID: 84919663377     PISSN: 01712004     EISSN: 18650325     Source Type: Book Series    
DOI: 10.1007/978-3-319-09665-0_6     Document Type: Conference Paper

References (141)

1. Al-Jarallah A, Trigatti BL (2010) A role for the scavenger receptor, class B type I in high density lipoprotein dependent activation of cellular signaling pathways. Biochim Biophys Acta 1801:1239–1248
2. Arakawa R, Yokoyama S (2002) Helical apolipoproteins stabilize ATP-binding cassette transporter A1 by protecting it from thiol protease-mediated degradation. J Biol Chem 277:22426-22429
3. Argraves KM, Gazzolo PJ, Groh EM et al (2008) High density lipoprotein-associated sphingosine 1-phosphate promotes endothelial barrier function. J Biol Chem 283:25074–25081
4. Argraves KM, Sethi AA, Gazzolo PJ et al (2011) S1P, dihydro-S1P and C24:1-ceramide levels in the HDL-containing fraction of serum inversely correlate with occurrence of ischemic heart disease. Lipids Health Dis 10:70
5. Assanasen C, Mineo C, Seetharam D et al (2005) Cholesterol binding, efflux, and a PDZ-interacting domain of scavenger receptor-BI mediate HDL-initiated signaling. J Clin Invest 115:969–977
6. Becker S, von Otte S, Robenek H et al (2011) Follicular fluid high-density lipoprotein-associated sphingosine 1-phosphate (S1P) promotes human granulosa lutein cell migration via S1P receptor type 3 and small G-protein RAC1. Biol Reprod 84:604–612
7. Bensinger SJ, Bradley MN, Joseph SB et al (2008) LXR signaling couples sterol metabolism to proliferation in the acquired immune response. Cell 134:97–111
8. Bodzioch M, Orso E, Klucken J et al (1999) The gene encoding ATP-binding cassette transporter 1 is mutated in Tangier disease. Nat Genet 22:347–351
9. Brooks-Wilson A, Marcil M, Clee SM et al (1999) Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency. Nat Genet 22:336–345
10. Cai L, Wang Z, Meyer JM et al (2012) Macrophage SR-BI regulates LPS-induced pro-inflammatory signaling in mice and isolated macrophages. J Lipid Res 53:1472–1481
11. Cavelier C, Ohnsorg PM, Rohrer L et al (2012) The β-chain of cell surface F(0)F(1) ATPase modulates apoA-I and HDL transcytosis through aortic endothelial cells. Arterioscler Thromb Vasc Biol 32:131–139
12. Chrisman TD, Perkins DT, Garbers DL (2003) Identification of a potent serum factor that causes desensitization of the receptor for C-Type natriuretic peptide. Cell Commun Signal 1:4
13. Christoffersen C, Obinata H, Kumaraswamy SB et al (2011) Endothelium-protective sphingosine- 1-phosphate provided by HDL-associated apolipoprotein M. Proc Natl Acad Sci USA 108:9613–9618
14. Chroni A, Liu T, Fitzgerald ML, Freeman MW et al (2004) Cross-linking and lipid efflux properties of apoA-I mutants suggest direct association between apoA-I helices and ABCA1. Biochemistry 43:2126–2139
15. Dahm F, Nocito A, Bielawska A et al (2006) Distribution and dynamic changes of sphingolipids in blood in response to platelet activation. J Thromb Haemost 4:2704–2709
16. Damirin A, Tomura H, Komachi M et al (2007) Role of lipoprotein-associated lysophospholipids in migratory activity of coronary artery smooth muscle cells. Am J Physiol Heart Circ Physiol 292:H2513–H2522
17. Danilo C, Gutierrez-Pajares JL et al (2013) Scavenger receptor class B type I regulates cellular cholesterol metabolism and cell signaling associated with breast cancer development. Breast Cancer Res 15:R87
18. Deeg MA, Bowen RF, Oram JF et al (1997) High density lipoproteins stimulate mitogen-activated protein kinases in human skin fibroblasts. Arterioscler Thromb Vasc Biol 17:1667–1674
19. Drobnik W, Borsukova H, Böttcher A et al (2002) Apo AI/ABCA1-dependent and HDL3- mediated lipid efflux from compositionally distinct cholesterol-based microdomains. Traffic 3:268–278
20. Dueñas AI, Aceves M, Fernández-Pisonero I et al (2008) Selective attenuation of Toll-like receptor 2 signalling may explain the atheroprotective effect of sphingosine 1-phosphate. Cardiovasc Res 79:537–544
21. Fabre AC, Vantourout P, Champagne E et al (2006) Cell surface adenylate kinase activity regulates the F(1)-ATPase/P2Y (13)-mediated HDL endocytosis pathway on human hepatocytes. Cell Mol Life Sci 63:2829–2837
22. Feng H, Guo L, Wang D et al (2011) Deficiency of scavenger receptor BI leads to impaired lymphocyte homeostasis and autoimmune disorders in mice. Arterioscler Thromb Vasc Biol 31:2543–2551
23. Fitzgerald ML, Morris AL, Rhee JS et al (2002) Naturally occurring mutations in the largest extracellular loops of ABCA1 can disrupt its direct interaction with apolipoprotein A-I. J Biol Chem 277:33178–33187
24. Fitzgerald ML, Morris AL, Chroni A et al (2004) ABCA1 and amphipathic apolipoproteins form high-affinity molecular complexes required for cholesterol efflux. J Lipid Res 45:287–294
25. Francis GA, Knopp RH, Oram JF (1995) Defective removal of cellular cholesterol and phospholipids by apolipoprotein A-I in Tangier disease. J Clin Invest 96:78–87
26. Frias MA, James RW, Gerber-Wicht C et al (2009) Native and reconstituted HDL activate Stat3 in ventricular cardiomyocytes via ERK1/2: role of sphingosine-1-phosphate. Cardiovasc Res 82:313–323
27. Frias MA, Lang U, Gerber-Wicht C et al (2010) Native and reconstituted HDL protect cardiomyocytes from doxorubicin-induced apoptosis. Cardiovasc Res 85:118–126
28. Glomset JA (1968) The plasma lecithin: cholesterol acyltransferase reaction. J Lipid Res 9:155-167
29. Gong M, Wilson M, Kelly T et al (2003) HDL-associated estradiol stimulates endothelial NO synthase and vasodilation in an SR-BI-dependent manner. J Clin Invest 111:1579–1587
30. González-Díez M, Rodríguez C, Badimon L et al (2008) Prostacyclin induction by high-density lipoprotein (HDL) in vascular smooth muscle cells depends on sphingosine 1-phosphate receptors: effect of simvastatin. Thromb Haemost 100:119–126
31. Graham DL, Oram JF (1987) Identification and characterization of a high density lipoproteinbinding protein in cell membranes by ligand blotting. J Biol Chem 262:7439–7442
32. Guo L, Song Z, Li M, Li XA et al (2009) Scavenger receptor BI protects against septic death through Its role in modulating inflammatory response. J Biol Chem 284:19826–19834
33. Haidar B, Mott S, Boucher B et al (2001) Cellular cholesterol efflux is modulated by phospholipidderived signaling molecules in familial HDL deficiency/Tangier disease fibroblasts. J Lipid Res 42:249–257
34. Haidar B, Denis M, Krimbou L et al (2002) cAMP induces ABCA1 phosphorylation activity and promotes cholesterol efflux from fibroblasts. J Lipid Res 43:2087–2094
35. Haidar B, Denis M, Marcil M et al (2004) Apolipoprotein A-I activates cellular cAMP signaling through the ABCA1 transporter. J Biol Chem 279:9963–9969
36. Hänel P, Andréani P, Gräler MH (2007) Erythrocytes store and release sphingosine 1-phosphate in blood. FASEB J 21:1202–1209
37. Hirano K, Matsuura F, Tsukamoto K et al (2000) Decreased expression of a member of the Rho GTPase family, Cdc42Hs, in cells from Tangier disease -the small G protein may play a role in cholesterol efflux. FEBS Lett 484:275–279
38. Hoekstra M, Van Berkel TJ, Van Eck M (2010) Scavenger receptor BI: a multi-purpose player in cholesterol and steroid metabolism. World J Gastroenterol 16:5916–5924
39. Holzer M, Birner-Gruenberger R, Stojakovic T et al (2011) Uremia alters HDL composition and function. J Am Soc Nephrol 22:1631–1641
40. Howard AD, Verghese PB, Arrese EL et al (2011) The β-subunit of ATP synthase is involved in cellular uptake and resecretion of apoA-I but does not control apoA-I-induced lipid efflux in adipocytes. Mol Cell Biochem 348:155–164
41. Hu YW, Ma X, Li XX et al (2009) Eicosapentaenoic acid reduces ABCA1 serine phosphorylation and impairs ABCA1-dependent cholesterol efflux through cyclic AMP/protein kinase A signaling pathway in THP-1 macrophage-derived foam cells. Atherosclerosis 204:e35–e43
42. Igarashi J, Miyoshi M, Hashimoto T et al (2007) Statins induce S1P1 receptors and enhance endothelial nitric oxide production in response to high-density lipoproteins. Br J Pharmacol 150:470–479
43. Imachi H, Murao K, Cao W et al (2003) Expression of human scavenger receptor B1 on and in human platelets. Arterioscler Thromb Vasc Biol 23:898–904
44. Iwamoto N, Lu R, Tanaka N, Abe-Dohmae S et al (2010) Calmodulin interacts with ATP binding cassette transporter A1 to protect from calpain-mediated degradation and upregulates highdensity lipoprotein generation. Arterioscler Thromb Vasc Biol 30:1446–1452
45. Karuna R, Park R, Othman A et al (2011) Plasma levels of sphingosine-1-phosphate and apolipoproteinMin patients with monogenic disorders of HDL metabolism. Atherosclerosis 219:855-863
46. Karwatsky J, Ma L, Dong F et al (2010) Cholesterol efflux to apoA-I in ABCA1-expressing cells is regulated by Ca2 + -dependent calcineurin signaling. J Lipid Res 51:1144–1156
47. Kimura T, Sato K, Kuwabara A et al (2001) Sphingosine 1-phosphate may be a major component of plasma lipoproteins responsible for the cytoprotective actions in human umbilical vein endothelial cells. J Biol Chem 276:31780–31785
48. Kimura T, Tomura H, Mogi C et al (2006) Role of scavenger receptor class B type I and sphingosine 1-phosphate receptors in high density lipoprotein-induced inhibition of adhesion molecule expression in endothelial cells. J Biol Chem 281:37457–37467
49. Kimura T, Mogi C, Tomura H et al (2008) Induction of scavenger receptor class B type I is critical for simvastatin enhancement of high-density lipoprotein-induced anti-inflammatory actions in endothelial cells. J Immunol 181:7332–7340
50. Kimura T, Tomura H, Sato K et al (2010) Mechanism and role of high density lipoprotein-induced activation of AMP-activated protein kinase in endothelial cells. J Biol Chem 285:4387–4397
51. Koseki M, Hirano K, Masuda D et al (2007) Increased lipid rafts and accelerated lipopolysaccharide-induced tumor necrosis factor-alpha secretion in Abca1-deficient macrophages. J Lipid Res 48:299–306
52. Krishna SM, Seto SW, Moxon JV et al (2012) Fenofibrate increases high-density lipoprotein and sphingosine 1 phosphate concentrations limiting abdominal aortic aneurysm progression in a mouse model. Am J Pathol 181:706–718
53. Landry YD, Denis M, Nandi S et al (2006) ATP-binding cassette transporter A1 expression disrupts raft membrane microdomains through its ATPase-related functions. J Biol Chem 281:36091–36101
54. Lee MH, Hammad SM, Semler AJ et al (2010) HDL3, but not HDL2, stimulates plasminogen activator inhibitor-1 release from adipocytes: the role of sphingosine-1-phosphate. J Lipid Res 51:2619–2628
55. Levkau B (2013) Cardiovascular effects of sphingosine-1-phosphate (S1P). Handb Exp Pharmacol 216:147–170
56. Li Q, Yokoyama S (1995) Independent regulation of cholesterol incorporation into free apolipoprotein-mediated cellular lipid efflux in rat vascular smooth muscle cells. J Biol Chem 270:26216–26223
57. Li Q, Tsujita M, Yokoyama S (1997) Selective down-regulation by protein kinase C inhibitors of apolipoprotein-mediated cellular cholesterol efflux in macrophages. Biochemistry 36:12045-12052
58. Liu D, Ji L, Tong X et al (2011) Human apolipoprotein A-I induces cyclooxygenase-2 expression and prostaglandin I-2 release in endothelial cells through ATP-binding cassette transporter A1. Am J Physiol Cell Physiol 301:C739–C748
59. Liu M, Seo J, Allegood J, Bi X et al (2013a) Hepatic ApoM overexpression stimulates formation of larger, ApoM/S1P-enriched plasma HDL. J Biol Chem 289:2801–2814
60. Liu XY, Lu Q, Ouyang XP et al (2013b) Apelin-13 increases expression of ATP-binding cassette transporter A1 via activating protein kinase C α signaling in THP-1 macrophage-derived foam cells. Atherosclerosis 226:398–407
61. Ma L, Dong F, Denis M et al (2011) Ht31, a protein kinase A anchoring inhibitor, induces robust cholesterol efflux and reverses macrophage foam cell formation through ATP-binding cassette transporter A1. J Biol Chem 286:3370–3378
62. Maceyka M, Harikumar KB, Milstien S et al (2012) Sphingosine-1-phosphate signaling and its role in disease. Trends Cell Biol 22:50–60
63. Malaval C, Laffargue M, Barbaras R et al (2009) RhoA/ROCK I signalling downstream of the P2Y13 ADP-receptor controls HDL endocytosis in human hepatocytes. Cell Signal 21:120-127
64. Malchinkhuu E, Sato K, Muraki T et al (2003) Assessment of the role of sphingosine 1-phosphate and its receptors in high-density lipoprotein-induced stimulation of astroglial cell function. Biochem J 370:817–827
65. Martinez LO, Agerholm-Larsen B, Wang N et al (2003a) Phosphorylation of a pest sequence in ABCA1 promotes calpain degradation and is reversed by ApoA-I. J Biol Chem 278:37368–37374
66. Martinez LO, Jacquet S, Esteve JP et al (2003b) Ectopic beta-chain of ATP synthase is an apolipoprotein A-I receptor in hepatic HDL endocytosis. Nature 421:75–79
67. Matsuo Y, Miura S, Kawamura A et al (2007) Newly developed reconstituted high-density lipoprotein containing sphingosine-1-phosphate induces endothelial tube formation. Atherosclerosis 194:159–168
68. McNeal CJ, Chatterjee S, Hou J et al (2013) Human HDL containing a novel apoC-I isoform induces smooth muscle cell apoptosis. Cardiovasc Res 98:83–93
69. Mendez AJ, Oram JF, Bierman EL (1991) Protein kinase C as a mediator of high density lipoprotein receptor-dependent efflux of intracellular cholesterol. J Biol Chem 266:10104-10111
70. Mineo C, Shaul PW (2012) Functions of scavenger receptor class B, type I in atherosclerosis. Curr Opin Lipidol 23:487–493
71. Mineo C, Yuhanna IS, Quon MJ et al (2003) High density lipoprotein induced endothelial nitricoxide synthase activation is mediated by Akt and MAP kinases. J Biol Chem 278:9142–9149
72. Miura S, Fujino M, Matsuo Y et al (2003) High density lipoprotein-induced angiogenesis requires the activation of Ras/MAP kinase in human coronary artery endothelial cells. Arterioscler Thromb Vasc Biol 23:802–808
73. Mogilenko DA, Orlov SV, Trulioff AS et al (2012) Endogenous apolipoprotein A-I stabilizes ATP-binding cassette transporter A1 and modulates Toll-like receptor 4 signaling in human macrophages. FASEB J 26:2019–2030
74. Morel S, Frias MA, Rosker C et al (2012) The natural cardioprotective particle HDL modulates connexin43 gap junction channels. Cardiovasc Res 93:41–49
75. Murphy AJ, Woollard KJ, Hoang A et al (2008) High-density lipoprotein reduces the human monocyte inflammatory response. Arterioscler Thromb Vasc Biol 28:2071–2077
76. Murphy AJ, Woollard KJ, Suhartoyo A et al (2011) Neutrophil activation is attenuated by highdensity lipoprotein and apolipoprotein A-I in in vitro and in vivo models of inflammation. Arterioscler Thromb Vasc Biol 31:1333–1341
77. Nofer JR, van Eck M (2011) HDL scavenger receptor class B type I and platelet function. Curr Opin Lipidol 22:277–282
78. Nofer J-R, Tepel M, Kehrel B et al (1996) High density lipoproteins enhance the Na+/H+ antiport in human platelets. Thromb Haemost 75:635–641
79. Nofer JR, Walter M, Kehrel B et al (1998) HDL3-mediated inhibition of thrombin-induced platelet aggregation and fibrinogen binding occurs via decreased production of phosphoinositidederived second messengers 1,2-diacylglycerol and inositol 1,4,5-tris-phosphate. Arterioscler Thromb Vasc Biol 18:861–869
80. Nofer JR, Fobker M, Höbbel G et al (2000) Activation of phosphatidylinositol-specific phospholipase C by HDL-associated lysosphingolipid. Involvement in mitogenesis but not in cholesterol efflux. Biochemistry 39:15199–15207
81. Nofer JR, Junker R, Pulawski E et al (2001a) High density lipoproteins induce cell cycle entry in vascular smooth muscle cells via mitogen activated protein kinase-dependent pathway. Thromb Haemost 85:730–735
82. Nofer JR, Levkau B, Wolinska I et al (2001b) Suppression of endothelial cell apoptosis by high density lipoproteins (HDL) and HDL-associated lysosphingolipids. J Biol Chem 276:34480-34485
83. Nofer JR, Feuerborn R, Levkau B et al (2003) Involvement of Cdc42 signaling in apoA-I-induced cholesterol efflux. J Biol Chem 278:53055–53062
84. Nofer JR, van der Giet M, Tölle M et al (2004) HDL induces NO-dependent vasorelaxation via the lysophospholipid receptor S1P3. J Clin Invest 113:569–581
85. Nofer JR, Remaley AT, Feuerborn R et al (2006) Apolipoprotein A-I activates Cdc42 signaling through the ABCA1 transporter. J Lipid Res 47:794–803
86. Nofer JR, Brodde M, Korporaal SJ et al (2011) Native high density lipoproteins inhibit thrombininduced platelet activation via scavenger receptor B1 (SR-B1). Atherosclerosis 215:374–382
87. Norata GD, Callegari E, Marchesi M et al (2005) High-density lipoproteins induce transforming growth factor-beta2 expression in endothelial cells. Circulation 111:2805–2811
88. Norata GD, Marchesi P, Pirillo A et al (2008) Long pentraxin 3, a key component of innate immunity, is modulated by high density lipoproteins in endothelial cells. Arterioscler Thromb Vasc Biol 28:925–931
89. Paatela H, Vihma V, Jauhiainen M et al (2011) Dehydroepiandrosterone fatty acyl esters in high density lipoprotein: interaction with human vascular endothelial cells and vascular responses ex vivo. Steroids 76:376–380
90. Radojkovic C, Genoux A, Pons V et al (2009) Stimulation of cell surface F1-ATPase activity by apolipoprotein A-I inhibits endothelial cell apoptosis and promotes proliferation. Arterioscler Thromb Vasc Biol 29:1125–1130
91. Riwanto M, Rohrer L, Roschitzki B et al (2013) Altered activation of endothelial anti- and proapoptotic pathways by high-density lipoprotein from patients with coronary artery disease: role of high-density lipoprotein-proteome remodeling. Circulation 127:891–904
92. Rust S, Rosier M, Funke H et al (1999) Tangier disease is caused by mutations in the gene encoding ATP-binding cassette transporter 1. Nat Genet 22:352–355
93. Sachinidis A, Kettenhofen R, Seewald S et al (1999) Evidence that lipoproteins are carriers of bioactive factors. Arterioscler Thromb Vasc Biol 19:2412–2421
94. Saddar S, Carriere V, Lee WR et al (2013) Scavenger receptor class B type I is a plasma membrane cholesterol sensor. Circ Res 112:140–151
95. Sano O, Kobayashi A, Nagao K et al (2007) Sphingomyelin-dependence of cholesterol efflux mediated by ABCG1. J Lipid Res 48:2377–2384
96. Sato K, Malchinkhuu E, Horiuchi Y et al (2007) HDL-like lipoproteins in cerebrospinal fluid affect neural cell activity through lipoprotein-associated sphingosine 1-phosphate. Biochem Biophys Res Commun 359:649–654
97. Sattler KJ, Elbasan S, Keul P et al (2010) Sphingosine 1-phosphate levels in plasma and HDL are altered in coronary artery disease. Basic Res Cardiol 105:821–832
98. See RH, Caday-Malcolm RA, Singaraja RR et al (2002) Protein kinase A site-specific phosphorylation regulates ATP-binding cassette A1 (ABCA1)-mediated phospholipid efflux. J Biol Chem 277:41835–41842
99. Seetharam D, Mineo C, Gormley AK et al (2006) High-density lipoprotein promotes endothelial cell migration and reendothelialization via scavenger receptor-B type I. Circ Res 98:63–72
100. Sekine Y, Suzuki K, Remaley AT (2011) HDL and sphingosine-1-phosphate activate stat3 in prostate cancer DU145 cells via ERK1/2 and S1P receptors, and promote cell migration and invasion. Prostate 71:690–699
101. Slotte JP, Oram JF, Bierman EL (1987) Binding of high density lipoproteins to cell receptors promotes translocation of cholesterol from intracellular membranes to the cell surface. J Biol Chem 262:12904–12907
102. Speer T, Rohrer L, Blyszczuk P et al (2013) Abnormal high-density lipoprotein induces endothelial dysfunction via activation of toll-like receptor-2. Immunity 38:754–768
103. Sun Y, Ishibashi M, Seimon T et al (2009) Free cholesterol accumulation in macrophage membranes activates Toll-like receptors and p38 mitogen-activated protein kinase and induces cathepsin K. Circ Res 104:455–465
104. Tamama K, Tomura H, Sato K et al (2005) High density lipoprotein inhibits migration of vascular smooth muscle cells through its sphingosine 1-phosphate component. Atherosclerosis 178:19-23
105. Tan JT, Prosser HC, Vanags LZ et al (2013) High-density lipoproteins augment hypoxia-induced angiogenesis via regulation of post-translational modulation of hypoxia-inducible factor 1α. FASEB J 28:206–217
106. Tang C, Vaughan AM, Oram JF (2004) Janus kinase 2 modulates the apolipoprotein interactions with ABCA1 required for removing cellular cholesterol. J Biol Chem 279:7622–7628
107. Tang C, Vaughan AM, Anantharamaiah GM et al (2006) Janus kinase 2 modulates the lipidremoving but not protein-stabilizing interactions of amphipathic helices with ABCA1. J Lipid Res 47:107–114
108. Tang C, Liu Y, Kessler PS, Vaughan AM, Oram JF (2009) The macrophage cholesterol exporter ABCA1 functions as an anti-inflammatory receptor. J Biol Chem 284:32336–32343
109. Tao R, Hoover HE, Honbo N et al (2010) High-density lipoprotein determines adult mouse cardiomyocyte fate after hypoxia-reoxygenation through lipoprotein-associated sphingosine 1-phosphate. Am J Physiol Heart Circ Physiol 298:H1022–H1028
110. Tatematsu S, Francis SA, Natarajan P et al (2013) Endothelial lipase is a critical determinant of high-density lipoprotein-stimulated sphingosine 1-phosphate-dependent signaling in vascular endothelium. Arterioscler Thromb Vasc Biol 33:1788–1794
111. Tölle M, Pawlak A, Schuchardt M et al (2008) HDL-associated lysosphingolipids inhibit NAD(P) H oxidase-dependent monocyte chemoattractant protein-1 production. Arterioscler Thromb Vasc Biol 28:1542–1548
112. Tölle M, Huang T, Schuchardt M et al (2012) High-density lipoprotein loses its anti-inflammatory capacity by accumulation of pro-inflammatory-serum amyloid A. Cardiovasc Res 94:154–162
113. Tsukamoto K, Hirano K, Tsujii K et al (2001) ATP-binding cassette transporter-1 induces rearrangement of actin cytoskeletons possibly through Cdc42/N-WASP. Biochem Biophys Res Commun 287:757–765
114. Tsukamoto K, Hirano K, Yamashita S et al (2002) Retarded intracellular lipid transport associated with reduced expression of Cdc42, a member of Rho-GTPases, in human aged skin fibroblasts: a possible function of Cdc42 in mediating intracellular lipid transport. Arterioscler Thromb Vasc Biol 22:1899–1904
115. Umemoto T, Han CY, Mitra P et al (2013) Apolipoprotein AI and high-density lipoprotein have anti-inflammatory effects on adipocytes via cholesterol transporters: ATP-binding cassette A-1, ATP-binding cassette G-1, and scavenger receptor B-1. Circ Res 112:1345–1354
116. Vaughan AM, Tang C, Oram JF (2009) ABCA1 mutants reveal an interdependency between lipid export function, apoA-I binding activity, and Janus kinase 2 activation. J Lipid Res 50:285–292
117. von Otte S, Paletta JR, Becker S et al (2006) Follicular fluid high density lipoprotein-associated sphingosine 1-phosphate is a novel mediator of ovarian angiogenesis. J Biol Chem 281:5398-5405
118. Walter M, Reinecke H, Nofer JR et al (1995) HDL3 stimulates multiple signaling pathways in human skin fibroblasts. Arterioscler Thromb Vasc Biol 15:1975–1986
119. Walter M, Reinecke H, Gerdes U et al (1996) Defective regulation of phosphatidylcholine-specific phospholipases C and D in a kindred with Tangier disease. Evidence for the involvement of phosphatidylcholine breakdown in HDL-mediated cholesterol efflux mechanisms. J Clin Invest 98:2315–2323
120. Wang N, Silver DL, Costet P, Tall AR (2000) Specific binding of ApoA-I, enhanced cholesterol efflux, and altered plasma membrane morphology in cells expressing ABC1. J Biol Chem 275:33053–33058
121. Wang N, Chen W, Linsel-Nitschke P et al (2003) A PEST sequence in ABCA1 regulates degradation by calpain protease and stabilization of ABCA1 by apoA-I. J Clin Invest 111:99–107
122. Wang N, Lan D, Chen W et al (2004) ATP-binding cassette transporters G1 and G4 mediate cellular cholesterol efflux to high-density lipoproteins. Proc Natl Acad Sci USA 101:9774-9779
123. Wang N, Ranalletta M, Matsuura F et al (2006) LXR-induced redistribution of ABCG1 to plasma membrane in macrophages enhances cholesterol mass efflux to HDL. Arterioscler Thromb Vasc Biol 26:1310–1316
124. Weichhart T, Kopecky C, Kubicek M et al (2012) Serum amyloid A in uremic HDL promotes inflammation. J Am Soc Nephrol 23:934–947
125. Westerterp M, Gourion-Arsiquaud S, Murphy AJ et al (2012) Regulation of hematopoietic stem and progenitor cell mobilization by cholesterol efflux pathways. Cell Stem Cell 11:195–206
126. Wilhelm AJ, Zabalawi M, Grayson JM et al (2009) Apolipoprotein A-I and its role in lymphocyte cholesterol homeostasis and autoimmunity. Arterioscler Thromb Vasc Biol 29:843–849
127. Wilkerson BA, Grass GD, Wing SB et al (2012) Sphingosine 1-phosphate (S1P) carrier-dependent regulation of endothelial barrier: high density lipoprotein (HDL)-S1P prolongs endothelial barrier enhancement as compared with albumin-S1P via effects on levels, trafficking, and signaling of S1P1. J Biol Chem 287:44645–44653
128. Xu J, Qian J, Xie X et al (2012) High density lipoprotein cholesterol promotes the proliferation of bone-derived mesenchymal stem cells via binding scavenger receptor-B type I and activation of PI3K/Akt, MAPK/ERK1/2 pathways. Mol Cell Biochem 371:55–64
129. Yamauchi Y, Hayashi M, Abe-Dohmae S et al (2003) Apolipoprotein A-I activates protein kinase C alpha signaling to phosphorylate and stabilize ATP binding cassette transporter A1 for the high density lipoprotein assembly. J Biol Chem 278:47890–47897
130. Yamauchi Y, Chang CC, Hayashi Met al (2004) Intracellular cholesterol mobilization involved in the ABCA1/apolipoprotein-mediated assembly of high density lipoprotein in fibroblasts. J Lipid Res 45:1943–1951
131. Yin K, Deng X, Mo ZC et al (2011) Tristetraprolin-dependent post-transcriptional regulation of inflammatory cytokine mRNA expression by apolipoprotein A-I: role of ATP-binding membrane cassette transporter A1 and signal transducer and activator of transcription 3. J Biol Chem 286:13834–13845
132. Yin K, Chen WJ, Zhou ZG et al (2012) Apolipoprotein A-I inhibits CD40 proinflammatory signaling via ATP-binding cassette transporter A1-mediated modulation of lipid raft in macrophages. J Atheroscler Thromb 19:823–836
133. Yuhanna IS, Zhu Y, Cox BE et al (2001) High-density lipoprotein binding to scavenger receptor- BI activates endothelial nitric oxide synthase. Nat Med 7:853–857
134. Yvan-Charvet L, Welch C, Pagler TA et al (2008) Increased inflammatory gene expression in ABC transporter-deficient macrophages: free cholesterol accumulation, increased signaling via toll-like receptors, and neutrophil infiltration of atherosclerotic lesions. Circulation 118:1837-1847
135. Yvan-Charvet L, Pagler TA, Seimon TA et al (2010a) ABCA1 and ABCG1 protect against oxidative stress-induced macrophage apoptosis during efferocytosis. Circ Res 106:1861–1869
136. Yvan-Charvet L, Pagler T, Gautier EL et al (2010b) ATP-binding cassette transporters and HDL suppress hematopoietic stem cell proliferation. Science 328:1689–1693
137. Zhang Z, Hirano K, Tsukamoto K et al (2005) Defective cholesterol efflux in Werner syndrome fibroblasts and its phenotypic correction by Cdc42, a RhoGTPase. Exp Gerontol 40:286–294
138. Zhang Q, Zhang Y, Feng H et al (2011) High density lipoprotein (HDL) promotes glucose uptake in adipocytes and glycogen synthesis in muscle cells. PLoS ONE 6:e23556
139. Zhang QH, Zu XY, Cao RX et al (2012) An involvement of SR-B1 mediated PI3K-Akt-eNOS signaling in HDL-induced cyclooxygenase 2 expression and prostacyclin production in endothelial cells. Biochem Biophys Res Commun 420:17–23
140. Zhu X, Lee JY, Timmins JM et al (2008a) Increased cellular free cholesterol in macrophagespecific Abca1 knock-out mice enhances pro-inflammatory response of macrophages. J Biol Chem 283:22930–22941
141. Zhu W, Saddar S, Seetharam D et al (2008b) The scavenger receptor class B type I adaptor protein PDZK1 maintains endothelial monolayer integrity. Circ Res 102:480–487